Clinical Trial Update: Intranasal Steroids for the Treatment of Nocturnal Enuresis With Associated Obstructive Sleep Apnea [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating intranasal steroids for nocturnal enuresis with obstructive sleep apnea was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturnal Enuresis
• Obstructive Sleep Apnea
• Sleep-disordered Breathing

Drugs mentioned

• Intranasal steroids (unspecified)

Snippet

Sponsor: University of Alberta | Conditions: Enuresis, Obstructive Sleep Apnea | Phase 4 | Status: WITHDRAWN